Related Experiment Video
Updated: May 6, 2026

Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
Innovation in Blood Establishment Processes, Strasbourg, 2025: a Conference Report
Marie Pflieger1, Annika Sepich1, Julie Harriague2
1European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
The European Directorate for the Quality of Medicines & Healthcare conference focused on innovations in blood establishment processes. Discussions centered on the new Substances of Human Origin (SoHO) Regulation for enhanced safety and supply continuity.
Area of Science:
- Transfusion Medicine
- Regulatory Science
- Public Health
Background:
- The European Union (EU) is transitioning from existing directives to the new Substances of Human Origin (SoHO) Regulation (EU) 2024/1938, effective in 2027.
- This regulatory shift aims to harmonize approaches across the EU for substances derived from human sources.
- Ensuring high quality and safety standards for SoHO is critical for donor and recipient protection and supply chain integrity.
Purpose of the Study:
- To summarize key discussions and innovations presented at the international EDQM Blood Conference.
- To explore the implications of the upcoming SoHO Regulation on blood establishment processes.
- To foster awareness regarding the benefits and challenges associated with implementing the new SoHO Regulation.
Main Methods:
- The report is based on the proceedings and discussions from the international EDQM Blood Conference on Innovation in Blood Establishment Processes.
- Key topics and expert insights shared during the conference sessions were documented.
- The focus was on identifying innovative practices and regulatory advancements in the blood sector.
Main Results:
- The conference highlighted the significant impact of the forthcoming SoHO Regulation on harmonizing quality and safety standards for blood and blood components.
- Participants shared diverse experiences and innovative strategies in blood donation and processing.
- The discussions underscored the need for preparedness to address both the advantages and hurdles in adopting the new regulatory framework.
Conclusions:
- The implementation of the SoHO Regulation is expected to enhance health protection and ensure a stable supply of critical SoHO.
- Collaboration and knowledge sharing are vital for successfully navigating the transition to the new regulatory landscape.
- Continued innovation in blood establishment processes is essential to meet evolving healthcare needs and regulatory requirements.
More Related Videos
14:22Ordering Single Cells and Single Embryos in 3D Confinement: A New Device for High Content Screening
Published on: September 18, 2016
07:53Megakaryocyte Culture in 3D Methylcellulose-Based Hydrogel to Improve Cell Maturation and Study the Impact of Stiffness and Confinement
Published on: August 26, 2021